文献速递甲状腺与浅表头颈介入US

超声引导微波消融联合乙醇注射治疗孤立性结节性胸骨后甲状腺肿:72例前瞻性研究

Ultrasound-guided microwave ablation combined with ethanol injection for the treatment of solitary nodular retrosternal goiter: a prospective study of 72 patients.
PubMed 文献 · Eur Radiol · 2022-08-17

该前瞻性研究纳入72例孤立性结节性胸骨后甲状腺肿患者,采用超声引导下微波消融联合乙醇注射治疗,平均随访23.89个月,结节体积从71.25 mL降至7.47 mL,平均体积缩小率90.99%,无严重并发症,8例(11.1%)需二次消融。结论认为该联合治疗有效安全,可作为特定患者的手术替代方案。

要点

  • 微波消融联合乙醇注射可使孤立性结节性胸骨后甲状腺肿体积显著缩小,平均VRR达90.99%。
  • 治疗后12个月颈围、症状评分和美容评分均显著改善。
  • 无严重并发症,11.1%结节需二次消融,需由经验丰富的医师操作。

关键影像表现/征象

  • 所有患者均成功完成治疗,无严重并发症发生。
  • 平均初始结节体积71.25 mL ± 61.61 mL,末次随访(平均23.89个月 ± 7.66个月,范围15-39个月)降至7.47 mL ± 9.19 mL。
  • 治疗12个月后颈围从36.94 cm ± 3.04 cm降至35.06 cm ± 2.84 cm,症状评分从3.78 ± 1.19降至0.36 ± 0.63,美容分级评分从3.42 ± 0.76降至1.13 ± 0.37(均P < 0.001)。

诊断标准与关键数值

  • 平均体积缩小率(VRR)为90.99% ± 7.52%。
  • 8例(11.1%)结节接受第二次消融。

临床应用与阅片要点

  • 超声和超声造影可用于随访监测结节体积变化和消融效果。
  • 该治疗应由经验丰富的医师操作,注意评估是否需要二次消融。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: We prospectively evaluated the efficacy and safety of microwave ablation (MWA) combined with ethanol injection (EI) in solitary nodular retrosternal goiters (RSGs).

METHODS: From November 2018 to November 2020, 72 patients diagnosed with solitary nodular RSG were treated by ultrasound-guided MWA with EI. Patients were followed up at 1, 3, 6, and 12 months and every 6-12 months thereafter by ultrasound and contrast-enhanced ultrasound (CEUS). The nodule volume, volume reduction ratio (VRR), neck circumference, symptom score, and cosmetic grading score were recorded to evaluate the treatment efficacy.

RESULTS: All patients successfully underwent treatment. The mean initial nodule volume was 71.25 mL ± 61.61 mL, which decreased significantly to 7.47 mL ± 9.19 mL at a mean follow-up time of 23.89 months ± 7.66 months (range 15-39 months) with a mean VRR of 90.99% ± 7.52%. The neck circumference, symptom score, and cosmetic grading score significantly decreased from 36.94 cm ± 3.04 cm to 35.06 cm ± 2.84 cm, from 3.78 ± 1.19 to 0.36 ± 0.63, and from 3.42 ± 0.76 to 1.13 ± 0.37, at the 12 months after treatment, respectively (all 7 p < 0.001). Of all the nodules, eight (11.1%) received a second ablation. No major complications occurred.

CONCLUSION: Ultrasound-guided MWA combined with EI is an effective and safe treatment for solitary nodular RSG and may be a potential alternative to surgery in selected patients, especially for those who are ineligible or unwilling to receive surgical treatment.

KEY POINTS: • MWA combined with EI is an effective and safe approach for the treatment of solitary nodular RSG. • This treatment should be conducted by experienced physicians. • It provides a potential alternative to surgery for solitary nodular RSG in patients who are ineligible or unwilling to receive surgical treatment.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Li, Li, Xiao, et al. Ultrasound-guided microwave ablation combined with ethanol injection for the treatment of solitary nodular retrosternal goiter: a prospective study of 72 patients. Eur Radiol. 2022. PMID: 35976394. doi:10.1007/s00330-022-09052-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。